Back
Terns Pharmaceuticals Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
50
TERN
Terns Pharmaceuticals
Last Price:
7.15
Seasonality Move:
-6.89%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TERN is experiencing selling pressure, which indicates risk of future bearish movement.
Terns Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.95 | Buy |
| 20-day SMA: | 7.2 | Buy |
| 50-day SMA: | 8.13 | Sell |
| 200-day SMA: | 7.07 | Buy |
| 8-day EMA: | 7.06 | Buy |
| 20-day EMA: | 7.29 | Sell |
| 50-day EMA: | 7.69 | Sell |
| 200-day EMA: | 7.34 | Sell |
Terns Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 45.85 | Sell |
| Chaikin Money Flow: | -602856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.88 - 7.86) | Sell |
| Bollinger Bands (100): | (6.87 - 8.97) | Sell |
Terns Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Terns Pharmaceuticals Stock
Is Terns Pharmaceuticals Stock a Buy?
- Terns Pharmaceuticals share price is 7.23 while TERN 8-day simple moving average is 6.95, which is a Buy signal.
- The stock price of TERN is 7.23 while Terns Pharmaceuticals 20-day SMA is 7.20, which makes it a Buy.
- Terns Pharmaceuticals 50-day simple moving average is 8.13 while TERN share price is 7.23, making it a Sell technically.
- TERN stock price is 7.23 and Terns Pharmaceuticals 200-day simple moving average is 7.07, creating a Buy signal.
TERN Technical Analysis vs Fundamental Analysis
Sell
50
Terns Pharmaceuticals (TERN)
is a Sell
Is Terns Pharmaceuticals a Buy or a Sell?
-
Terns Pharmaceuticals stock is rated a Sell
The current Terns Pharmaceuticals [TERN] share price is $7.23. The Score for TERN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Terns Pharmaceuticals Stock Info
Market Cap:
508.79M
Price in USD:
7.23
Share Volume:
822.08K
Terns Pharmaceuticals 52-Week Range
52-Week High:
11.40
52-Week Low:
3.26
Sell
50
Terns Pharmaceuticals (TERN)
is a Sell
Terns Pharmaceuticals Share Price Forecast
-
What is the Terns Pharmaceuticals stock price today?
The Terns Pharmaceuticals stock price is 7.23 USD today. -
Will TERN stock go up or go down?
Terns Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Terns Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Terns Pharmaceuticals is overvalued.
Is Terns Pharmaceuticals Stock a Buy?
- Terns Pharmaceuticals share price is 7.23 while TERN 8-day exponential moving average is 7.06, which is a Buy signal.
- The stock price of TERN is 7.23 while Terns Pharmaceuticals 20-day EMA is 7.29, which makes it a Sell.
- Terns Pharmaceuticals 50-day exponential moving average is 7.69 while TERN share price is 7.23, making it a Sell technically.
- TERN stock price is 7.23 and Terns Pharmaceuticals 200-day simple moving average is 7.34, creating a Sell signal.
Fundamental Analysis of Terns Pharmaceuticals
Is Terns Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Terns Pharmaceuticals
Should I short Terns Pharmaceuticals stock?
- TERN Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Terns Pharmaceuticals is a Sell
- Terns Pharmaceuticals Relative Strength Index (RSI) is 45.85, which suggest Terns Pharmaceuticals is oversold
- The Bollinger Bands (25) for Terns Pharmaceuticals is (6.88 - 7.86), which suggest Terns Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Terns Pharmaceuticals is (6.87 - 8.97), which suggest Terns Pharmaceuticals is a Sell
* Terns Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.